| ADCC | Antibody-dependent cell-mediated cytotoxicity |
| APCs | Antigen-presenting cells |
| CRS | Cytokine release syndrome |
| DDS | Drug delivery system |
| HLA-E | Human leukocyte antigen-E |
| IFN-γ | Interferon-γ |
| IL-12R | Interleukin 12 receptor |
| IL-15 | Interleukin 15 |
| IL-15R | Interleukin 15 receptor |
| IL-18R | Interleukin 18 receptor |
| IL-21R | Interleukin 21 receptor |
| IL-2R | Interleukin 2 receptor |
| ISs | Immune synapses |
| KIRs | Killer cell immunoglobulin-like receptors |
| MHC | Major histocompatibility complex |
| MHT | Mild magnetothermal therapy |
| NCAM | Neural cell adhesion molecule |
| NCR1 | Natural cytotoxic triggering receptor 1 |
| NEO | NK-derived exosomes |
| NK | Natural killer |
| NKG2A | Natural Killer Group 2A |
| PBMCs | Peripheral blood monocytes |
| PD-1 | Programmed death 1 |
| PDA | Polydopamine |
| PS | Phosphatidylserine |
| ROS | Reactive oxygen species |
| siRNAs | Small interfering nucleic acids |
| Tim-3 | T-cell immunoglobulin and mucin domain Containing protein-3 |
| TNFR | Tumor necrosis factor receptor |
| TNF-α | Tumor necrosis factor-α |
| Tregs | Inhibiting regulatory T cells |
| ULBPs | UL16-binding proteins |